DOT1L, a methyltransferase that catalyzes the methylation of histone H3 lysine 79 residues, is known to promote tumorigenesis in MLL-rearranged leukemia, with aberrant expression related to poor clinical outcomes. Here, KMT2A is linked to leukemia.